Last reviewed · How we verify
NCT06114862
Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 2)
NA trial testing Stigma-reduction intervention in Stigma, Social. Withdrawn.
14 March 2025
Quick facts
| Lead sponsor | Harvard University |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Start date | 1 October 2024 |
| Primary completion | 14 March 2025 |
| Estimated completion | 14 March 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Stigma-reduction intervention
Conditions studied
- Stigma, Social — all drugs for Stigma, Social →
- Mental Health Issue — all drugs for Mental Health Issue →
Sponsor
Harvard University
Who can join
18 and older, any sex, with Stigma, Social or Mental Health Issue. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial is part of a series of brief interventions to reduce suicide risk in collaboration with the social media platform RallyPoint, a site specifically designed for U.S. servicemembers and veterans to connect with one another. This RCT (Intervention 2: Stigma Reduction) is focused on decreasing the stigma associated with sharing one's personal experiences related to mental health on the RallyPoint site. Specifically, the investigators will test the effect of a psychoeducational intervention that will provide participants information on the potential benefits of self-disclosure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06114862
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Stigma-reduction intervention
Trials testing the same drug.
- NCT05446064 — Buddhism Beliefs and HIV Stigma in Thailand · NA · terminated
Other recruiting trials for Stigma, Social
Currently open trials in the same condition.
- NCT07430761 — ET Stigma Response to Tremor Suppression · recruiting
- NCT04881084 — Exploring Empathy and Compassion Using Digital Narratives · NA · recruiting
- NCT05174936 — ResIlience-based Stigma REdUction Program ("Rise-up") · NA · active not recruiting
- NCT05704764 — Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances · NA · active not recruiting
- NCT05404750 — Harm Reduction in HIV Primary Care for PLWH Who Use Drugs · recruiting
Other Harvard University trials
Trials by the same sponsor.
- NCT07316647 — Using Conversational AI to Teach Growth Mindset Skills to Youths in India · NA · completed
- NCT07394465 — First Tones: Artistic Communal Practices for 4 and 5 Year Old Children · NA · completed
- NCT06217705 — Testing the Effects of Project Calm in Ukrainian Schools · NA · completed
- NCT06114875 — Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 1) · NA · terminated
- NCT06114849 — Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 3) · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06114862 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Harvard University
- Last refreshed: 13 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06114862.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing